# Varenicline (Chantix™) for the Treatment of Alcohol Dependence

> **NCT00705523** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 40 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00705523
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-03
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705523, "Varenicline (Chantix™) for the Treatment of Alcohol Dependence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00705523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*